SEC 13F Intelligence

Marshall Wace, LLP / JNJ

Marshall Wace, LLP’s Johnson & Johnson Position

Does Marshall Wace, LLP own Johnson & Johnson (JNJ)? Yes — 2.38M shares worth $581M (+0.58% of its 13F portfolio) as of Q1 2026, down from 3.67M shares the prior filed quarter.

Position Value
$581M
Q1 2026
Shares
2.38M
% of Portfolio
+0.58%
Quarters Held
27
currently held

Position History JNJ

Reported value by quarter
Q4 ’18: $348,000Q4 ’18Q1 ’19: $29MQ3 ’19: $89MQ4 ’19: $81MQ1 ’20: $98MQ1 ’20Q2 ’20: $27MQ3 ’20: $2MQ1 ’21: $10MQ2 ’21: $68MQ2 ’21Q3 ’21: $72MQ4 ’21: $415MQ1 ’22: $348MQ2 ’22: $514MQ2 ’22Q3 ’22: $368MQ4 ’22: $79MQ1 ’23: $65MQ2 ’23: $285MQ2 ’23Q4 ’23: $16MQ1 ’24: $101MQ2 ’24: $568MQ3 ’24: $854MQ3 ’24Q4 ’24: $587MQ1 ’25: $151MQ2 ’25: $242MQ3 ’25: $665MQ3 ’25Q4 ’25: $759MQ1 ’26: $581Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.38M$581M+0.58%
Q4 20253.67M$759M+0.69%
Q3 20253.58M$665M+0.67%
Q2 20251.58M$242M+0.27%
Q1 2025912.9K$151M+0.19%
Q4 20244.06M$587M+0.71%
Q3 20245.27M$854M+1.04%
Q2 20243.88M$568M+0.76%
Q1 2024640.1K$101M+0.15%
Q4 2023101.3K$16M+0.03%
Q2 20231.72M$285M+0.56%
Q1 2023417.9K$65M+0.14%
Q4 2022449.4K$79M+0.18%
Q3 20222.25M$368M+0.81%
Q2 20222.89M$514M+1.06%
Q1 20221.96M$348M+0.66%
Q4 20212.43M$415M+0.77%
Q3 2021444.9K$72M+0.30%
Q2 2021409.8K$68M+0.31%
Q1 202160.1K$10M+0.05%
Q3 202016.3K$2M+0.02%
Q2 2020195.2K$27M+0.19%
Q1 2020746.6K$98M+0.98%
Q4 2019554.7K$81M+0.56%
Q3 2019689.0K$89M+0.70%
Q1 2019211.0K$29M+0.14%
Q4 20182.7K$348,0000.00%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Marshall Wace, LLP’s full portfolio or all institutional holders of JNJ.